Are P2Y12 reaction unit (PRU) and % inhibition index equivalent for the expression of P2Y12 inhibition by the VerifyNow® assay? Role of haematocrit and haemoglobin levels

被引:28
|
作者
Voisin, Sophie [1 ,2 ]
Bongard, Vanina [2 ,3 ]
Tidjane, Mohammed A. [2 ,4 ]
Lhermusier, Thibault [2 ,4 ]
Carrie, Didier [2 ,4 ]
Sie, Pierre [1 ,2 ,5 ]
机构
[1] CHU Toulouse, Haematol Lab, Toulouse, France
[2] Univ Toulouse 3, F-31062 Toulouse, France
[3] CHU Toulouse, Dept Epidemiol, Toulouse, France
[4] CHU Toulouse, Dept Cardiol, Toulouse, France
[5] CHU Toulouse, INSERM, U1048, Toulouse, France
关键词
VerifyNow (R); P2Y(12) assay; haematocrit; haemoglobin; PERCUTANEOUS CORONARY INTERVENTION; OF-CARE ASSAY; PLATELET REACTIVITY;
D O I
10.1160/TH11-01-0046
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The results of the whole blood VerifyNow (R) P2Y(12) assay can be expressed as platelet reaction units (PRU) or % inhibition index ((%)inh), but an optimal cut-off for the assessment of high on-treatment platelet reactivity (HPR) predictive of clinical events has been validated only for PRU. The aim of the study was to study the influence of haematological variables, such as platelet and leukocyte counts or haematocrit / haemoglobin, within the limits indicated by the manufacturer for assay validity, on the results of the test. We performed a comparison of PRU and (%)inh in a series 186 samples obtained from a clinical trial on patients under dual antiplatelet therapy. The results show that PRU significantly decreases with increasing haematocrit / haemoglobin, whereas (%)inh does not, due to a parallel change in PRU and iso-TRAP baseline value. PRU and % inhibition index are not equivalent for the definition of HPR, because of their different sensitivities to haematocrit / haemoglobin.
引用
收藏
页码:227 / 229
页数:3
相关论文
共 50 条
  • [21] The Roles and Issues of P2Y12 Percent Inhibition Assessed by VerifyNow Assay for Patients Undergoing Neurointervention: A Prospective Study
    Kashiwazaki, Daina
    Kuwayama, Naoya
    Akioka, Naoki
    Hayakawa, Yumiko
    Kuroda, Satoshi
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2014, 23 (07): : 1830 - 1836
  • [22] VerifyNow® P2Y12 assay for thienopyridine resistance: Single-centre experience
    Francisco, A. R.
    Patel, R. K.
    Melikian, N.
    Byrne, J.
    Roberts, L. N.
    Chitongo, P.
    Ford, E.
    Arya, R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 : 29 - 29
  • [23] Inhibition of platelet aggregation by GLS-409, an antagonist of both P2Y1 and P2Y12, is distinct from inhibition by selective P2Y1 and P2Y12 antagonists
    Gremmel, T.
    Yanachkov, I. B.
    Wright, G.
    Michelson, A. D.
    Frelinger, A. L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 516 - 516
  • [24] VerifyNow P2Y12 Parameters in Non-Drug Users
    Lee, Young Kyung
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 138 : A342 - A342
  • [25] Role of P2Y12 Receptor in Thrombosis
    Zhang, Yaqi
    Zhang, Si
    Ding, Zhongren
    THROMBOSIS AND EMBOLISM: FROM RESEARCH TO CLINICAL PRACTICE, VOL 1, 2017, 906 : 307 - 324
  • [26] Analysis of VerifyNow P2Y12 testing at an urban hospital system
    Oliphant, Carrie
    Covert, Ashley
    Van Berkel, Megan
    Hutchison, Lydia
    Swiggart, Cortney
    PHARMACOTHERAPY, 2017, 37 (12): : E144 - E144
  • [27] Antiplatelet Therapy n ACS Patients: Comparing Appropriate P2Y12 Inhibition by Clopidogrel to the Use of New P2Y12 Inhibitors
    Ristorto, Jessica
    Messas, Nathan
    Marchandot, Benjamin
    Kibler, Marion
    Hess, Sebastien
    Meyer, Nicolas
    Schaeffer, Michael
    Tuzin, Nicolas
    Ohlmann, Patrick
    Jesel, Laurence
    Morel, Olivier
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2018, 25 (08) : 674 - 689
  • [28] Rapid P2Y12 Inhibition Still an Unmet Medical Need
    Silvain, Johanne
    Montalescot, Gilles
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2012, 5 (03) : 328 - 331
  • [29] Characteristics of new P2Y12 inhibitors: selection of P2Y12 inhibitors in clinical practice
    Golino, Paolo
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2013, 14 : S22 - S30
  • [30] Decreased platelet inhibition by P2Y12 receptor blockers in anaemia
    Wadowski, Patricia P.
    Kopp, Christoph W.
    Koppensteiner, Renate
    Lang, Irene M.
    Pultar, Joseph
    Lee, Silvia
    Weikert, Constantin
    Panzer, Simon
    Gremmel, Thomas
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2018, 48 (01)